WashU Pitch Competition : Breakthrough ideas to address neurodegenerative disease

Exocel Bio was selected as a finalist in a global pitch competition recognizing innovative biotech solutions. Our presentation addressed the critical challenges of crossing the blood–brain barrier and introduced a novel exosome-based approach for the treatment of epilepsy. This recognition highlights our commitment to advancing targeted, regenerative therapeutics through scientific innovation and translational research.